Pankaj Mohan Ph.D.
Net Worth

Last updated:

What is Pankaj Mohan Ph.D. net worth?

The estimated net worth of Dr. Pankaj Mohan Ph.D. is at least $4,145,381 as of 27 Oct 2023. He owns shares worth $184,531 as insider and has received compensation worth at least $3,960,850 in Sonnet BioTherapeutics Holdings, Inc..

What is the salary of Pankaj Mohan Ph.D.?

Dr. Pankaj Mohan Ph.D. salary is $792,170 per year as Founder, Chairman. Chief Executive Officer & Pres in Sonnet BioTherapeutics Holdings, Inc..

How old is Pankaj Mohan Ph.D.?

Dr. Pankaj Mohan Ph.D. is 60 years old, born in 1965.

What stocks does Pankaj Mohan Ph.D. currently own?

As insider, Dr. Pankaj Mohan Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Sonnet BioTherapeutics Holdings, Inc. (SONN) Founder, Chairman. Chief Executive Officer & Pres 59,526 $3.1 $184,531

What does Sonnet BioTherapeutics Holdings, Inc. do?

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

SONN logo
SONN
Sonnet BioTherapeutics Holdings, Inc.
$3.1

Pankaj Mohan Ph.D. insider trading

Sonnet BioTherapeutics Holdings, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 34,375 $1.6 $55,000
Purchase
Warrant to Purchase Common Stock 68,750 $1.6 $110,000
Purchase
Common Stock 371,600 $0.22 $82,867
Purchase
Common Stock 60,000 $0.59 $35,100
Purchase
Common Stock 4,000 $1.55 $6,180
Purchase
Common Stock 28,000 $1.55 $43,400
Purchase
Common Stock 2,400 N/A N/A

Sonnet BioTherapeutics Holdings key executives

Sonnet BioTherapeutics Holdings, Inc. executives and other stock owners filed with the SEC: